Caption Management, LLC Assembly Biosciences, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$2.13 - $3.46 $479,250 - $778,500	-225,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $78,500 - $97,500	-25,000 Reduced 10.0%	225,000 $783,000
Q2 2021 Aug 16, 2021	BUY	$3.8 - $4.56 $950,000 - $1.14 Million	250,000 New	250,000 $970,000
Q4 2019 Feb 13, 2020	SELL	$8.36 - $23.81 $435,555 - $1.24 Million	-52,100 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $285,090 - $459,680	22,100 Added 73.67%	52,100 $703,000
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $531,000 - $747,900	30,000 New	30,000 $590,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.